Nationwide Fund Advisors Has $2,050,000 Position in Vascular Solutions Inc. (VASC)
Nationwide Fund Advisors raised its position in shares of Vascular Solutions Inc. (NASDAQ:VASC) by 57.6% during the second quarter, Holdings Channel reports. The firm owned 49,212 shares of the medical device company’s stock after buying an additional 17,983 shares during the period. Nationwide Fund Advisors owned approximately 0.28% of Vascular Solutions worth $2,050,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of VASC. Bank of Montreal Can acquired a new stake in Vascular Solutions during the second quarter worth about $202,000. JPMorgan Chase & Co. boosted its stake in Vascular Solutions by 37.0% in the second quarter. JPMorgan Chase & Co. now owns 5,131 shares of the medical device company’s stock worth $214,000 after buying an additional 1,387 shares during the period. BNP Paribas Arbitrage SA boosted its stake in Vascular Solutions by 52.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,772 shares of the medical device company’s stock worth $282,000 after buying an additional 2,324 shares during the period. Menta Capital LLC acquired a new stake in Vascular Solutions during the first quarter worth about $320,000. Finally, BB&T Corp acquired a new stake in Vascular Solutions during the second quarter worth about $359,000. Hedge funds and other institutional investors own 82.08% of the company’s stock.
Shares of Vascular Solutions Inc. (NASDAQ:VASC) traded down 0.70% during midday trading on Thursday, hitting $46.56. 8,373 shares of the stock traded hands. Vascular Solutions Inc. has a 1-year low of $24.34 and a 1-year high of $50.72. The stock has a 50 day moving average of $48.49 and a 200 day moving average of $41.94. The company has a market capitalization of $814.38 million, a P/E ratio of 86.22 and a beta of 0.54.
Vascular Solutions (NASDAQ:VASC) last released its quarterly earnings data on Monday, July 25th. The medical device company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.03. The business had revenue of $41.20 million for the quarter, compared to analyst estimates of $41.40 million. Vascular Solutions had a return on equity of 16.32% and a net margin of 6.22%. Vascular Solutions’s revenue was up 9.7% compared to the same quarter last year. During the same period last year, the firm posted $0.29 earnings per share. Equities research analysts predict that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.
A number of analysts have issued reports on VASC shares. Canaccord Genuity reiterated a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. Zacks Investment Research raised shares of Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a research report on Thursday, July 28th. TheStreet raised shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th. Needham & Company LLC initiated coverage on shares of Vascular Solutions in a research report on Thursday, October 6th. They issued a “buy” rating and a $58.00 price target on the stock. Finally, Sidoti lowered shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target on the stock. in a research report on Tuesday, July 12th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $49.50.
In other news, VP William Rutstein sold 10,011 shares of Vascular Solutions stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total transaction of $463,108.86. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Howard Root sold 40,000 shares of Vascular Solutions stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total value of $1,804,400.00. Following the sale, the chief executive officer now directly owns 347,840 shares in the company, valued at $15,691,062.40. The disclosure for this sale can be found here. 6.90% of the stock is owned by corporate insiders.
Vascular Solutions Company Profile
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Want to see what other hedge funds are holding VASC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vascular Solutions Inc. (NASDAQ:VASC).
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.